Ergawealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$245K Sell
212
-2
-0.9% -$2.36K 0.1% 47
2026
Q2
$257K Buy
+214
New +$219K 0.1% 48
2026
Q1
– Sell
-201
Closed -$216K – 58
2025
Q4
$216K Buy
+201
New +$192K 0.1% 53
2025
Q3
– Sell
-626
Closed -$488K – 71
2025
Q2
$488K Buy
626
+24
+4% +$18.6K 0.22% 46
2025
Q1
$497K Sell
602
-18
-3% -$15K 0.25% 39
2024
Q4
$479K Sell
620
-9
-1% -$7.45K 0.24% 40
2024
Q3
$557K Sell
629
-2
-0.3% -$1.8K 0.28% 36
2024
Q2
$571K Sell
631
-4
-0.6% -$3.2K 0.31% 33
2024
Q1
$494K Buy
635
+10
+2% +$7.12K 0.27% 32
2023
Q4
$364K Sell
625
-2
-0.3% -$1.17K 0.22% 36
2023
Q3
$337K Sell
627
-23
-4% -$11.9K 0.23% 37
2023
Q2
$305K Hold
650
– – 0.21% 35
2023
Q1
$223K Hold
650
– – 0.18% 43
2022
Q4
$238K Buy
+650
New +$230K 0.22% 42

Other funds holding LLY

Ergawealth Advisors's LLY Position: Q3 2026 in Review

Ergawealth Advisors reduced its Eli Lilly (LLY) stake by 0.93% in Q3 2026, selling an estimated $2.36K and leaving 212 shares worth $245K. The position accounts for 0.1% of the portfolio, ranked #47.

Ergawealth Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $571K in Q2 2024. 1,260 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Ergawealth Advisors held 212 shares of Eli Lilly worth $245K as of Q3 2026.
  • Ergawealth Advisors sold 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 0.1% of Ergawealth Advisors's portfolio in Q3 2026, its #47 holding.
  • Ergawealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Ergawealth Advisors's Eli Lilly position peaked at $571K in Q2 2024.
  • 1,260 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ergawealth Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.